[1]
T. T. X. Lê, T. K. N. Tạ, T. Q. Phạm, and T. N. Nguyễn, “THE PREVALENCE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE 2ND DOSE OF VERO CELL (SINOPHARM) COVID-19 VACCINE AMONG PEOPLE VACCINATED AT THE VACCINATION SITE OF HANOI MEDICAL UNIVERSITY AND SOME RELATED FACTORS, 2021-2022”, VMJ, vol. 540, no. 2, Jul. 2024.